Awards & Advancement

Trovagene names new vice president

Friday, February 17, 2012 12:46 PM

Trovagene, a developer of transrenal molecular diagnostics, has named Charlie Rodi, Ph.D., vice president and chief technology officer.

More... »

Sangart appoints three to leadership team

Friday, February 17, 2012 12:43 PM

Sangart, a privately held biopharmaceutical company focused on oxygen-therapeutic agents, has appointed three new members to its executive team.

More... »


Delcath appoints Chris Houchins senior VP

Tuesday, February 14, 2012 07:50 AM

Delcath Systems has appointed J. Chris Houchins to the company's clinical development team as senior vice president, clinical and medical affairs.

More... »

Premier Research names Sean Russell marketing VP

Monday, February 13, 2012 03:53 PM

Premier Research Group has appointed Sean Russell vice president, marketing.

More... »

iKnowMed Ranked No. 1 EHR in Oncology/Hematology

Saturday, February 11, 2012 07:48 AM

iKnowMed Electronic Health Record (EHR) System, a product of McKesson Specialty Health and the US Oncology Network, has been named the highest ranked overall EHR vendor for oncology and hematology practices by the 2012 Black Book Rankings Survey. 

More... »

Clinical Research Advantage named among az magazine’s ‘Top 25 Workplaces for Women’

Friday, February 10, 2012 11:50 AM

Clinical Research Advantage (CRA), a trial management organization based in Tempe, Ariz., has been selected among az magazine’s top 25 workplaces for women.

More... »

Unigene appoints Mayes and Pepper to biotechnologies SBU

Friday, February 10, 2012 11:48 AM

Unigene Laboratories announced the expansion of its biotechnologies strategic business unit (SBU) with the promotion of Gregory T. Mayes to chief business officer and appointment of Jane Pepper to senior director, business development.

More... »

MMG names Chris Middleton vice president of technology

Friday, February 10, 2012 11:47 AM

MMG, a global clinical trials patient recruitment group, part of Ketchum, has appointed Chris Middleton vice president of technology.

More... »

Blueprint Medicines names Christoph Lengauer chief scientific officer

Friday, February 10, 2012 11:44 AM

Blueprint Medicines, a Cambridge, Mass.-based developer of personalized cancer therapies, has appointed Christoph Lengauer, Ph.D., chief scientific officer.

More... »

Paul Fonteyne named president, CEO of Boehringer Ingelheim USA

Friday, February 10, 2012 11:42 AM

Paul R. Fonteyne has been promoted to U.S. country managing director and president and CEO of Boehringer Ingelheim USA. Fonteyne assumes this role from J. Martin Carroll, who remains with the company in a corporate strategy and development role and a member of the board.

More... »

`

CWWeekly

February 21

Survey: Sponsors, CROs making changes to their business models to demonstrate value to payers

Cegedim ranks top pharma companies on their use of, and success with, social media

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs